Suchergebnisse - "Hlatky, Mark A"

Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association von Parikh, Nisha I, Gonzalez, Juan M, Anderson, Cheryl A M, Judd, Suzanne E, Rexrode, Kathryn M, Hlatky, Mark A, Gunderson, Erica P, Stuart, Jennifer J, Vaidya, Dhananjay

“… This statement summarizes evidence that adverse pregnancy outcomes (APOs) such as hypertensive disorders of pregnancy, preterm delivery, gestational diabetes, …”
Weitere Angaben

Increasing value and reducing waste in research design, conduct, and analysis von Ioannidis, John P A, Greenland, Sander, Hlatky, Mark A, Khoury, Muin J, Macleod, Malcolm R, Moher, David, Schulz, Kenneth F, Tibshirani, Robert

“… Correctable weaknesses in the design, conduct, and analysis of biomedical and public health research studies can produce misleading results and waste valuable …”
Volltext

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines von Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Jr, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph

Weitere Angaben

Willingness to Pay for High-Cost Medications von Hlatky, Mark A

Weitere Angaben

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines von Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Jr, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph

Weitere Angaben

Utilization and Outcomes of Measuring Fractional Flow Reserve in Patients With Stable Ischemic Heart Disease von Parikh, Rushi V, Liu, Grace, Plomondon, Mary E, Sehested, Thomas S G, Hlatky, Mark A, Waldo, Stephen W, Fearon, William F

“… The use and clinical outcomes of fractional flow reserve (FFR) measurement in patients with stable ischemic heart disease (SIHD) are uncertain, as prior …”
Weitere Angaben

Rheumatoid arthritis and cardiovascular disease von Crowson, Cynthia S., Liao, Katherine P., Davis, John M., Solomon, Daniel H., Matteson, Eric L., Knutson, Keith L., Hlatky, Mark A., Gabriel, Sherine E.

“… Rheumatic disease and heart disease share common underpinnings involving inflammation. The high levels of inflammation that characterize rheumatic diseases …”
Volltext

Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation von Shah, Rashmee U, Freeman, James V, Shilane, David, Wang, Paul J, Go, Alan S, Hlatky, Mark A

“… The purpose of this study was to estimate rates and identify predictors of inpatient complications and 30-day readmissions, as well as repeat hospitalization …”
Weitere Angaben

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines von Greenland, Philip, Alpert, Joseph S, Beller, George A, Benjamin, Emelia J, Budoff, Matthew J, Fayad, Zahi A, Foster, Elyse, Hlatky, Mark A, Hodgson, John McB, Kushner, Frederick G, Lauer, Michael S, Shaw, Leslee J, Smith, Jr, Sidney C, Taylor, Allen J, Weintraub, William S, Wenger, Nanette K, Jacobs, Alice K

Weitere Angaben

Functional Testing or Coronary Computed Tomography Angiography in Patients With Stable Coronary Artery Disease von Jørgensen, Mads E, Andersson, Charlotte, Nørgaard, Bjarne L, Abdulla, Jawdat, Shreibati, Jacqueline B, Torp-Pedersen, Christian, Gislason, Gunnar H, Shaw, Richard E, Hlatky, Mark A

“… The choice of either anatomical or functional noninvasive testing to evaluate suspected coronary artery disease might affect subsequent clinical management and …”
Weitere Angaben

Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization von Head, Stuart J, Milojevic, Milan, Daemen, Joost, Ahn, Jung-Min, Boersma, Eric, Christiansen, Evald H, Domanski, Michael J, Farkouh, Michael E, Flather, Marcus, Fuster, Valentin, Hlatky, Mark A, Holm, Niels R, Hueb, Whady A, Kamalesh, Masoor, Kim, Young-Hak, Mäkikallio, Timo, Mohr, Friedrich W, Papageorgiou, Grigorios, Park, Seung-Jung, Rodriguez, Alfredo E, Sabik, 3rd, Joseph F, Stables, Rodney H, Stone, Gregg W, Serruys, Patrick W, Kappetein, A Pieter

“… Coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) are used for coronary revascularization in patients with multivessel and …”
Weitere Angaben

Association of spontaneous bleeding and myocardial infarction with long-term mortality after percutaneous coronary intervention von Kazi, Dhruv S, Leong, Thomas K, Chang, Tara I, Solomon, Matthew D, Hlatky, Mark A, Go, Alan S

“… Platelet inhibition after percutaneous coronary intervention (PCI) reduces the risk of myocardial infarction (MI) but increases the risk of bleeding. MIs and …”
Weitere Angaben

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines von Greenland, Philip, Alpert, Joseph S, Beller, George A, Benjamin, Emelia J, Budoff, Matthew J, Fayad, Zahi A, Foster, Elyse, Hlatky, Mark A, Hodgson, John McB, Kushner, Frederick G, Lauer, Michael S, Shaw, Leslee J, Smith, Jr, Sidney C, Taylor, Allen J, Weintraub, William S, Wenger, Nanette K, Jacobs, Alice K

Weitere Angaben

Cost-effectiveness of preparticipation screening for prevention of sudden cardiac death in young athletes von Wheeler, Matthew T, Heidenreich, Paul A, Froelicher, Victor F, Hlatky, Mark A, Ashley, Euan A

“… Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness …”
Weitere Angaben

β-blocker therapy and cardiac events among patients with newly diagnosed coronary heart disease von Andersson, Charlotte, Shilane, David, Go, Alan S, Chang, Tara I, Kazi, Dhruv, Solomon, Matthew D, Boothroyd, Derek B, Hlatky, Mark A

“… The effectiveness of beta-blockers for preventing cardiac events has been questioned for patients who have coronary heart disease (CHD) without a prior …”
Weitere Angaben

RESPONSE: A Mentor's Perspective on Using Shared Research Data von Hlatky, Mark A

Weitere Angaben

Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure von Baras Shreibati, Jacqueline, Goldhaber-Fiebert, Jeremy D, Banerjee, Dipanjan, Owens, Douglas K, Hlatky, Mark A

“… This study assessed the cost-effectiveness of left ventricular assist devices (LVADs) as destination therapy in ambulatory patients with advanced heart …”
Weitere Angaben

Unmet need for hypercholesterolemia care in 35 low- and middle-income countries: A cross-sectional study of nationally representative surveys von Marcus, Maja E., Ebert, Cara, Geldsetzer, Pascal, Theilmann, Michaela, Bicaba, Brice Wilfried, Andall-Brereton, Glennis, Bovet, Pascal, Farzadfar, Farshad, Singh Gurung, Mongal, Houehanou, Corine, Malekpour, Mohammad-Reza, Martins, Joao S., Moghaddam, Sahar Saeedi, Mohammadi, Esmaeil, Norov, Bolormaa, Quesnel-Crooks, Sarah, Wong-McClure, Roy, Davies, Justine I., Hlatky, Mark A., Atun, Rifat, Bärnighausen, Till W., Jaacks, Lindsay M., Manne-Goehler, Jennifer, Vollmer, Sebastian

“… As the prevalence of hypercholesterolemia is increasing in low- and middle-income countries (LMICs), detailed evidence is urgently needed to guide the response …”
Volltext

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials von Hlatky, Mark A, Boothroyd, Derek B, Bravata, Dena M, Boersma, Eric, Booth, Jean, Brooks, Maria M, Carrié, Didier, Clayton, Tim C, Danchin, Nicolas, Flather, Marcus, Hamm, Christian W, Hueb, Whady A, Kähler, Jan, Kelsey, Sheryl F, King, Spencer B, Kosinski, Andrzej S, Lopes, Neuza, McDonald, Kathryn M, Rodriguez, Alfredo, Serruys, Patrick, Sigwart, Ulrich, Stables, Rodney H, Owens, Douglas K, Pocock, Stuart J

“… Coronary artery bypass graft (CABG) and percutaneous coronary intervention (PCI) are alternative treatments for multivessel coronary disease. Although the …”
Volltext

Differential Dynamics of the Maternal Immune System in Healthy Pregnancy and Preeclampsia von Han, Xiaoyuan, Ghaemi, Mohammad S., Ando, Kazuo, Peterson, Laura S., Ganio, Edward A., Tsai, Amy S., Gaudilliere, Dyani K., Stelzer, Ina A., Einhaus, Jakob, Bertrand, Basile, Stanley, Natalie, Culos, Anthony, Tanada, Athena, Hedou, Julien, Tsai, Eileen S., Fallahzadeh, Ramin, Wong, Ronald J., Judy, Amy E., Winn, Virginia D., Druzin, Maurice L., Blumenfeld, Yair J., Hlatky, Mark A., Quaintance, Cecele C., Gibbs, Ronald S., Carvalho, Brendan, Shaw, Gary M., Stevenson, David K., Angst, Martin S., Aghaeepour, Nima, Gaudilliere, Brice

“… Preeclampsia is one of the most severe pregnancy complications and a leading cause of maternal death. However, early diagnosis of preeclampsia remains a …”
Volltext